Andrew N. Schiff

Insider Reports History

Entity
Individual
Location
Planet Zanett Inc, 135 E 57 Th St, New York, NY
Signature
/s/ Markus Warmuth, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew N. Schiff:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aclaris Therapeutics, Inc. Director Common Stock 434K $547K $1.26 Jun 1, 2024 By Aisling Capital IV LP
Aclaris Therapeutics, Inc. Director Common Stock 9.17K $11.6K $1.26 Jun 1, 2024 Direct
Aclaris Therapeutics, Inc. Director Restricted Stock Units 4.79K $4.94K $1.03 Jun 6, 2024 Direct
Monte Rosa Therapeutics, Inc. Director Stock Option (Right to Buy) 22.1K Jun 12, 2024 Direct
Aclaris Therapeutics, Inc. Director Stock Option (Right to Buy) 15.8K Jun 6, 2024 Direct

Insider Reports Filed by Andrew N. Schiff

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GLUE Monte Rosa Therapeutics, Inc. Jun 12, 2024 1 $0 4 Jun 13, 2024 Director
ACRS Aclaris Therapeutics, Inc. Jun 6, 2024 2 $0 4 Jun 10, 2024 Director
ACRS Aclaris Therapeutics, Inc. Jun 1, 2024 2 $0 4 Jun 4, 2024 Director
GLUE Monte Rosa Therapeutics, Inc. Jun 14, 2023 1 $0 4 Jun 15, 2023 Director
ACRS Aclaris Therapeutics, Inc. Jun 1, 2023 4 $0 4 Jun 5, 2023 Director
ACRS Aclaris Therapeutics, Inc. Nov 10, 2022 3 -$920K 4 Nov 14, 2022 Director
ACRS Aclaris Therapeutics, Inc. Oct 24, 2022 3 -$700K 4 Oct 26, 2022 Director
ACRS Aclaris Therapeutics, Inc. Oct 17, 2022 2 -$862K 4 Oct 19, 2022 Director
ACRS Aclaris Therapeutics, Inc. Oct 7, 2022 1 -$118K 4 Oct 11, 2022 Director
ACRS Aclaris Therapeutics, Inc. Oct 4, 2022 2 -$749K 4 Oct 6, 2022 Director
ACRS Aclaris Therapeutics, Inc. Jun 17, 2022 1 -$296K 4 Jun 21, 2022 Director
GLUE Monte Rosa Therapeutics, Inc. Jun 15, 2022 1 $0 4 Jun 16, 2022 Director
ACRS Aclaris Therapeutics, Inc. Jun 2, 2022 4 $0 4 Jun 6, 2022 Director
GLUE Monte Rosa Therapeutics, Inc. Jun 23, 2021 1 $0 4 Jun 25, 2021 Director
GLUE Monte Rosa Therapeutics, Inc. Jun 23, 2021 0 $0 3 Jun 23, 2021 Director
ACRS Aclaris Therapeutics, Inc. Jun 3, 2021 2 $0 4 Jun 4, 2021 Director